Neurodawn Pharmaceutical Co., Ltd.
Clinical trials sponsored by Neurodawn Pharmaceutical Co., Ltd., explained in plain language.
-
Doctors test direct brain injection to fight devastating stroke
Disease control Not yet recruitingThis early study is testing a new drug called RK-4, injected directly into the brain through the skull, for people who have just had a severe stroke and cannot receive standard treatments. The main goal is to see if this injection is safe and how the body handles the drug, while …
Phase: PHASE1, PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill aims to tame debilitating shingles pain
Symptom relief Not yet recruitingThis study is testing a new drug called Y-4 to see if it can safely reduce the long-lasting nerve pain some people get after a shingles rash heals. About 160 adults in China with this condition will take either the new Y-4 tablets or a standard pain medication (pregabalin) for 14…
Phase: PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC